Medicare Enrolled
Kristen McCorquodale, PA-C
Medical Physician Assistant · San Antonio, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about McCorquodale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you McCorquodale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about McCorquodale
Kristen McCorquodale is a medical physician assistant in San Antonio, TX, with 7 years of NPI registration. Based on federal Medicare data, McCorquodale performed 2,994 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, McCorquodale received a total of $7,487 from 46 pharmaceutical and/or device companies across 215 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for McCorquodale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 7 years of NPI registration
▲ Top 5% volume in TX
$7,487 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,994
Medicare services
Top 5% in TX for medical physician assistant
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,161 | $4 | $13 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
516 | $74 | $246 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
336 | $31 | $131 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $48 | $176 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
219 | $52 | $198 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
156 | $64 | $221 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
79 | $30 | $98 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
65 | $99 | $329 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
35 | $77 | $475 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
22 | $65 | $226 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
22 | $255 | $776 |
| Chemical peel of face A procedure that applies a chemical solution to the face to remove the outer layer of skin. |
21 | $219 | $780 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
16 | $37 | $197 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
16 | $266 | $823 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
15 | $66 | $238 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
12 | $108 | $345 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
10.0% medium
89.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,487
Total received (2021-2024)
Avg $1,872/year across 4 years
Top 7% in TX for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
215
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,687
2023
$1,617
2022
$1,483
2021
$1,701
Payments by company (2024)
Janssen Biotech, Inc.
$464
E.R. Squibb & Sons, L.L.C.
$349
Galderma Laboratories, L.P.
$346
ABBVIE INC.
$259
Krystal Biotech Inc
$186
Lilly USA, LLC
$172
Dermavant Sciences, Inc.
$162
Regeneron Healthcare Solutions, Inc.
$159
UCB, Inc.
$128
Arcutis Biotherapeutics, Inc.
$103
Incyte Corporation
$94
Kerecis Limited
$89
LEO Pharma Inc.
$76
Amgen Inc.
$49
GENZYME CORPORATION
$34
Biofrontera Inc.
$16
Top 3 companies account for 43.1% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$1,510
Incyte Corporation
$500
Galderma Laboratories, L.P.
$444
Regeneron Healthcare Solutions, Inc.
$406
Lilly USA, LLC
$355
E.R. Squibb & Sons, L.L.C.
$349
ABBVIE INC.
$329
Janssen Scientific Affairs, LLC
$329
GENZYME CORPORATION
$249
Ortho Dermatologics, a division of Bausch Health US, LLC
$234
Abbott Laboratories
$232
AbbVie Inc.
$219
UCB, Inc.
$202
EPI Health, LLC
$191
Krystal Biotech Inc
$186
Novo Nordisk Inc
$177
Dermavant Sciences, Inc.
$162
Kerecis Limited
$159
VYNE Pharmaceuticals Inc.
$152
Almirall LLC
$110
Arcutis Biotherapeutics, Inc.
$103
LEO Pharma Inc.
$97
NOVARTIS PHARMACEUTICALS CORPORATION
$93
Journey Medical Corporation
$85
Biohaven Pharmaceutical Holding Company Ltd.
$81
MERZ NORTH AMERICA, INC.
$67
Biogen, Inc.
$65
Amgen Inc.
$49
MAYNE PHARMA COMMERCIAL LLC
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Exact Sciences Corporation
$25
Medtronic, Inc.
$25
Optinose US, Inc.
$22
Medimetriks Pharmaceuticals, Inc.
$20
SI-BONE, INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Paratek Pharmaceuticals, Inc.
$19
Bigfoot Biomedical Inc
$17
IBSA Pharma Inc.
$17
Biofrontera Inc.
$16
MAYNE PHARMA INC.
$16
LIFESCAN, INC.
$16
GlaxoSmithKline, LLC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 32.8% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · AUSTEDO · Bimzelx · CLODERM · COSENTYX · Cimzia · Clindacin ETZ · Cologuard Collection Kit · DUOBRII · DUPIXENT · EMGALITY · ENSTILAR · INTELLIS ADAPTIVESTIM · Kerecis Omega3 SurgiClose · Kerendia · Klisyri · LIBTAYO · LICART · NURTEC ODT · NUZYRA · OCTRODE · OLUMIANT · OPZELURA · Otezla · PROCLAIM · REMICADE · RINVOQ · Rybelsus · SHINGRIX · SKYRIZI · Seysara · Sotyktu · TALTZ · TREMFYA · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · VRAYLAR · VTAMA · VYJUVEK · VenaSeal · WYNZORA · Wegovy · XIFAXAN · Xeomin · Xhance · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical physician assistants in nearby ZIP areas
307
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
Brooke Army Medical Center (FT Sam Houston)
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
McCorquodale is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is McCorquodale experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, McCorquodale performed 1,161 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does McCorquodale receive payments from pharmaceutical companies?
Yes. McCorquodale received a total of $7,487 from 46 companies across 215 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do McCorquodale's costs compare to other medical physician assistants in San Antonio?
McCorquodale's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for McCorquodale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Physician Assistants in San Antonio
Browse medical physician assistants in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Medical Physician Assistants in TX
Medical physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Physician Assistants in TX
Which TX medical physician assistants receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology